Illinois SB0126 mandates coverage for diagnostic testing and FDA-approved treatments for Alzheimer's and related dementias.
Illinois SB0126 requires health insurance policies and managed care plans to cover medically necessary diagnostic testing and FDA-approved treatments or medications prescribed to slow the progression of Alzheimer's disease or related dementias. This coverage must comply with specific sections of the Illinois Insurance Code and cannot be subject to step therapy. The bill also includes provisions for the calculation of refunds or additional premiums and mandates that certain information be provided to enrollees. Effective January 1, 2027.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.